BIOGRAPHY

Do Minh Thai

Do Minh Thai was influential in the statistical programming of ZEG Berlin studies since inception, and is responsible for the planning and delivery of all programming activities.

Do Minh Thai
Director, Statistics and Methodology

Do Minh Thai brings four decades of experience in biostatistics to his role as Director of Statistics and Methodology. Influential since the inception of ZEG Berlin, he has comprehensive knowledge in the analysis of clinical and epidemiological studies with particular expertise in the management of large databases. He coordinates the complex statistical analysis on multiple ZEG Berlin projects.

Thai studied mathematics at the University of Greifswald (Germany), receiving his PhD in Mathematical Cybernetics and Computer Sciences in 1977. Throughout his career Thai has established himself as a reputable partner delivering exacting study design, data management and data analysis.

PUBLICATIONS

Pregnancy and pregnancy outcomes in a prospective cohort study: Final Results from the Nexplanon Observational Risk Assessment Study (NORA) Reed Suzanne, Do Minh Thai, Jens A. Lange, Koro Carol, Klaas Heinemann Contraception. 2022; 10.1016/j.contraception.2022.109920. https://www.contraceptionjournal.org/article/S0010-7824(22)00443-7/fulltext

Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) Reed Suzanne, Do Minh Thai, Jens A. Lange, Koro Carol, Fox Michelle, Klaas Heinemann Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052. https://doi.org/10.1016/j.contraception.2019.03.052

Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study Clare Barnett, Dinger Jürgen, Do Minh Thai, Klaas Heinemann Contraception & Reproductive Health Care. 2019; 1-4. 10.1080/13625187.2019.1629412. https://doi.org/10.1080/13625187.2019.1629412

Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study Clare Barnett, Moehner Sabine, Do Minh Thai, Klaas Heinemann The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5. http://www.tandfonline.com/doi/full/10.1080/13625187.2017.1412427

IUD use among parous women and risk of uterine perforation: a secondary analysis Klaas Heinemann, Clare Barnett, Reed Suzanne, Moehner Sabine, Do Minh Thai Contraception. 2017; Volume 95, Issue 6, Pages 605–607. http://dx.doi.org/10.1016/j.contraception.2017.03.007

Fertility and combined oral contraceptives – unintended pregnancies and planned pregnancies following oral contraceptive use – results from the INAS-SCORE study Clare Barnett, Hagemann Christine, Dinger Jürgen, Do Minh Thai, Klaas Heinemann Eur J Contracept Reprod health Care. 2016; Oct 17:1-7. 10.1080/13625187.2016.1241991. https://dx.doi.org/10.1080/13625187.2016.1241991

Impact of Estrogen Type on Cardiovascular Safety of Combined Oral Contraceptives Dinger Jürgen, Do Minh Thai, Klaas Heinemann Contraception. 2016; Oct;94(4):328-39. 10.1016/j.contraception.2016.06.010. https://www.ncbi.nlm.nih.gov/pubmed/27343748

Influence of age and BMI on risk of venous thromboembolism: a meta-analysis of 246,513 women using combined oral contraceptives based on 521,516 women-years. Clare Barnett, Bauerfeind Anja, Do Minh Thai, Klaas Heinemann Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070. http://onlinelibrary.wiley.com/doi/10.1002/pds.4070/abstract

Intrauterine Devices and the Risk of Uterine Perforations: Final Results from the EURAS-IUD 5-years study Klaas Heinemann, Moehner Sabine, Do Minh Thai, Reed Suzanne Pharmacoepidemiology and Drug Safety. 2016; Aug;25:(S3):3-680. 10.1002/pds.4070. http://onlinelibrary.wiley.com/doi/10.1002/pds.4070/abstract

Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices. Klaas Heinemann, Reed Suzanne, Moehner Sabine, Do Minh Thai Contraception. 2015; Apr;91(4):280-3. 10.1016/j.contraception.2015.01.011. https://www.ncbi.nlm.nih.gov/pubmed/25601350

Risk of uterine perforation with levonorgestrel-releasing and copper intrauterine devices in the European Active Surveillance Study on Intrauterine Devices. Klaas Heinemann, Reed Suzanne, Moehner Sabine, Do Minh Thai Contraception. 2015; 10.1016/j.contraception.2015.01.007. https://www.ncbi.nlm.nih.gov/pubmed/25601352

Cardiovascular Safety in Users of Different Combined Oral Contraceptives – Final Results from the INAS-SCORE study Bardenheuer Kristina, Klaas Heinemann, Do Minh Thai, Franke Christian Pharmac. 2015; (24) S1, 1–587. 10.1002/pds.3838. http://onlinelibrary.wiley.com/doi/10.1002/pds.3838/full

Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation „pill scare“ Heinemann Lothar A, Dinger Jürgen, Assmann Anita, Do Minh Thai Contraception. 2010; May;81(5):401-7. 10.1016/j.contraception.2009.12.014. https://dx.doi.org/10.1016/j.contraception.2009.12.014

No increased risk of colon cancer associated with various HRT formulations: a case-control study Dinger Jürgen, Heinemann Lothar A, Do Minh Thai, Assmann Anita BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-7-76

Comparison of incidence/risk of venous thromboembolism (VTE) among selected clinical and hereditary risk markers: a community-based cohort study Spannagl M, Heinemann Lothar A, Do Minh Thai, Assmann Anita, Schramm W, Schuermann R Thrombosis Journal . 2005; 3:8 (20 Jul 2005). DOI: 10.1186/1477-9560-3-8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1181827/

12 Next »